Dyne Therapeutics, Inc. · NASDAQ:DYN
Kerr Douglas sold 887 Dyne Therapeutics, Inc. shares (Form 4)
Traded Jun 16, 2026 · Filed Jun 17, 2026
On Jun 16, 2026, Kerr Douglas (Chief Medical Officer) sold 887 Dyne Therapeutics, Inc. shares at US$18.33 for US$16,259 under a trading plan, leaving 169,155 shares. Filed Jun 17, 2026 (Form 4).
- Sold
- 887 shares
- Price
- US$18.33
- Value
- US$16,259
- Holding after
- 169,155 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Common Stock | Sale | 887 | US$18.33 | 169,155 | Direct |
Source
Related
- Dyne Therapeutics, Inc.
- Kerr Douglas
- Dyne Therapeutics, Inc. shareholders
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Kerr Douglas · Aug 17, 2026
- Form 4 · Kerr Douglas · May 14, 2026
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Rhodes Jason P · Aug 17, 2026
- Form 4 · Cox John · Aug 17, 2026